2020 US Democrat presidential candidates speak to seniors on Rx prices

2 August 2019

How will US Democratic presidential candidates lower drug prices for seniors if they become President? This is a question many will be asking ahead of the US elections.

Seventeen candidates recently spoke to advocacy group AARP - the American Association of Retired Persons - and the Des Moines Register about high prescription costs and their broader health care plan. Here are some of their views.

Former Vice President Joe Biden: “I would set up an independent commission at the Department of Health and Human Services that would bring in experts from around the country that would, in fact, take a look at the research and the cost of going in to develop that drug, and set the initial price of that drug. After that, if they get a patent on that drug … they cannot raise it beyond the cost of inflation at that time.”

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK